Thermablate EAS is a lightweight, fully automated, portable balloon treatment for heavy bleeding, used to carry out global endometrial ablation in just 2 minutes. The device is entirely self-contained, requires minimal set-up, and plugs directly into an electrical wall outlet for immediate use.
Manufacturer: Idoman Teoranta
Thermablate is included in RCOGs list of second generation ablation devices.
Thermablate EAS is easy to operate and fluid pressure and volume are entirely monitored by the unit itself, and need not be supervised continuously by the operator. Thermablate does not cause charring and adhesions post ablation, allowing for inspections of the cavity even after several years, reducing the need for hysterectomy.
Thermablate EAS has successfully reduced total treatment time of global ablation to less than 2.5 minutes, making it a simple, safe and effective procedure that can be conducted conveniently in an outpatient setting.
Efficacy and Tolerability
Long Term Efficacy Thermablate China Study (pdf)Download
Long Term Follow Up Paper UK - 2016 Powell & Chen (pdf)Download
TB_ effectiveness_Journal_of_O&G (pdf)Download
Thermablate 8 year follow up (pdf)Download
Two year results Thermablate_Greece (pdf)Download
Paul Byrne - TB & Mirena (pdf)Download
Long term follow up TB Outpatients (pdf)Download
Outpatient Treatment of Menorrhagia TB Denmark (pdf)Download
5 year Follow Up - NS vs TB - Nottingham Data (pdf)Download
Longterm follow up TB V Novasure_UK 2017 (pdf)Download
Northern Ireland Study,JOMIG Abstract2010 (1) (pdf)Download